Rivaroxaban (Bio-synectics)

N/A

Report date: 2022/10/13 11:07:31

Base Information

Drug NameRivaroxaban (Bio-synectics)

Drug Alias NameIncrementally modified drug (IMD) of Xarelto ( (Bio-synectics))BS-112

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFactor Xa inhibitors

TargetsCoagulation factor X

Therapy Area/IndicationsVenous ThrombosisPulmonary Embolism

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBio-Synectics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsVenous ThrombosisPulmonary Embolism

Inactive IndicationsN/A

ATC CodeN/A